Registered entities
EQUILLIUM, INC.
Reg. No. 1746466United States
EQUILLIUM, INC
Reg. No. 82-1554746United States
Innovation
3 patent families — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 163 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Social engagement
Social engagement: 5.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include ADAR1 Capital Management, Janus Henderson Investors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 38% |
| Private equity | 2 | 25% |
| Other / undisclosed | 3 | 38% |
Recent activity
18 Jun 2026
Event
American Association of Immunologists meeting
8 Jun 2026
Leadership hire
Chief Development Officer
22 May 2026
Event
Virtual investor event on Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis